An open-label, non-controlled trial of prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation. - An open-label, non-controlled trial of prophylactic administration of voriconazole in patients who undergo allogeneic hematopoietic stem cell transplantation.

ational Hospital Organization Nagoya Medical Center0 个研究点目标入组 30 人开始时间: 2017年5月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with proven/probable invasive fungal infection at the time of acquisition of informed consent (patients can be registered if cure is confirmed at the time of participation in the study and an antifungal drug is not used for therapeutic purpose). 2)Patients with a history of hypersensitivity to the components of voriconazole. 3)Patients with creatinine clearance less than 30 ml/min at the time of participation in the study. 4)Patients with grade C by Child-Pugh classification. 5)Patients with a complication of cardiac disease (including arrhythmia) which requires treatment. 6)Patients with a mental disorder, a psychiatric symptom, or cognitive impairment. 7)Patients who are pregnant, possibly pregnant, or breastfeed. 8)Patients who are taking or scheduled to be administered a prohibited drug concomitantly with voriconazole. 9)Patients under HIV treatment. 10)Patients for whom the principal investigator or other investigators decided not suitable for participation in this study.

发起方

ational Hospital Organization Nagoya Medical Center